Cited by 598Mitochondrial Function and PathologyAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

The DOI matches its Crossref record.

Cytochrome oxidase deficiency in Alzheimer’s disease

Parker, William Davis, Filley, Christopher M., Parks, Janice K.·1990·Neurology

DOI 10.1212/wnl.40.8.1302

Open this paper in CoChat — free account

Abstract

We assayed cytochrome oxidase and other electron transport chain activities in platelet mitochondria isolated from patients with Alzheimer's disease (AD). Five of 6 patients had striking reductions of platelet cytochrome oxidase activity (patient mean, 83.72 +/- 82.99 nmol/min/mg; control mean, 167.14 +/- 36.21 nmol/min/mg; n = 8). Other electron transport chain catalytic activities were not significantly different than control values. AD may be a systemic illness, a primary defect in cytochrome oxidase may be pathogenically important in its production, and the mitochondrial genes encoding cytochrome oxidase subunits may be important in producing the defect.

Integrity signals

Registry

Crossref · 10.1212/wnl.40.8.1302

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 501–597 of 597

Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice
Kondak, C., Leith, M., Baddeley, T. C., Santos, R. X., Harrington, C. R., Wischik, C. M., Riedel, G., & Klein, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310810 · Cited by 5
“Decreased complex IV activity was also found in AD patients [8,40,41] and co-localized with tau pathology [42].”
Background
Effects of Novel Tacrine Derivatives on Mitochondrial Energy Metabolism and Monoamine Oxidase Activity—In Vitro Study
Hroudová, J., Nováková, T., Korábečný, J., Maliňák, D., Górecki, L., & Fišar, Z. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02172-1 · Cited by 5
Sodium-azide-induced learning deficits in rats: Time course and corresponding pathology
Croll, S. D., Greene, N. A., Lindsay, R. M., & Wiegand, S. J. (1997) · Psychobiology · doi:10.3758/bf03327025 · Cited by 5
Inhibition of Cytochrome Oxidase Impairs Learning and Hippocampal Plasticity: a Novel Animal Model of Alzheimer’s Disease
Bennett, M. C., Diamond, D. M., Parker, W. D., Stryker, S. L., & Rose, G. M. (1992) · Advances in behavioral biology · doi:10.1007/978-1-4615-3432-7_35 · Cited by 5
Self-citation
Importance of platelet functions in Alzheimer's disease
Hasitz, M., Rácz, Z., Nagy, A., et al. (1995) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(95)00645-2 · Cited by 5
“It was published that the activity of cytochrome oxidase of Alzheimer platelets decreased markedly (Parker et al., 1990), but van Zuylen et al.”
Background
Possible reversal of ageing and other mitochondrial deficiencies through retroviral transfection of mitochondrially encoded proteins to the nucleus
Hoeben, P. (1993) · Medical Hypotheses · doi:10.1016/0306-9877(93)90058-x · Cited by 5
Impact of the 25th chromosome on mitochondrial dysfunction in human disease
Walker, U. A., Jean-Francois, B., & Byrne, E. (1995) · Journal of Clinical Neuroscience · doi:10.1016/0967-5868(95)90001-2 · Cited by 5
Mitochondrial DNA Mutations, Pathogenicity and Inheritance
Houshmand, M. (2003) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 5
Cytochrome Oxidase
Abdollahian, N. P., Cada, A. M., Gonzalez-Lima, F., & de la Torre, J. C. (1998) · Springer eBooks · doi:10.1007/978-1-4757-9936-1_9 · Cited by 7
Therapeutic Strategies in Alzheimer’s Disease
Beal, M. F. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4116-4_49 · Cited by 5
Alterations in Mitochondrial Function in Pulmonary Vascular Diseases
Farha, S., Asosingh, K., Hassoun, P. M., Barnard, J., Comhair, S., Reichard, A., Wanner, N., Radeva, M., Aldred, M. A., Beck, G. J., et al. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0557 · Cited by 4
“Recent work suggests that platelets can serve as a valid measure of mitochondrial function in diseases (Ben-Shachar et al., 2007; Guo et al., 2009; Parker et al., 1990a, 1990b; Parker et al., 1989; Rezania et al., 2017; Sangiorgi et al., 1994; Shi et al., 2008; Zharikov and Shiva, 2013).”
Single‐cell landscape of sex‐specific drivers of Alzheimer's disease
Wu, Y., Travaglini, K. J., Gabitto, M. I., Keene, C. D., Dunn, A. R., Kaczorowski, C. C., Jager, P. L. D., Menon, V., Schneider, J. A., Bennett, D. A. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.71041 · Cited by 9
Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets
Sharma, Y., Gupta, J. K., Babu, M. A., Singh, S., & Sindhu, R. K. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02269-5 · Cited by 6
“Deficiencies in both these enzymes have also been found previously in the brain and other tissues of AD patients (Parker et al. 1990).”
Mitochondrial Dysfunction and Molecular Bases of Neurodegenerative Diseases
Kolesnikova, E. E. (2013) · Neurophysiology · doi:10.1007/s11062-013-9341-1 · Cited by 4
Impaired mitochondrial energy metabolism
Das, B. B., Ray, P., & Raut, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00004-8 · Cited by 6
ET-MSF: a model stacking framework to identify electron transport proteins
Wang, Y., Pan, Q., Liu, X., & Ding, Y. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2701012 · Cited by 4
“In studies, electron transporter abnormalities have been found to be associated with diseases such as idiopathic diabetes [5–8], Parkinson’s disease [4], and Alzheimer’s disease [9–12].”
Background
Toxin Induced Mitochondrial Dysfunction and Neurodegeneration
Sabri, M. I. (1998) · Springer eBooks · doi:10.1007/978-3-662-12509-0_14 · Cited by 5
Rapid Inhibition by Sodium Azide of the Phosphoinositide-Mediated Calcium Response to Serotonin Stimulation in Human Platelets: Preservation in Alzheimer's Disease
Hedin, H. L. M., Eriksson, S., & Fowler, C. J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3154 · Cited by 4
Neurotoxic Effects of Repetitive Inhibition of Oxidative Phosphorylation in Young Adults Surfacing With Deficits of Spatial Learning in Old Age
Lohmann, P., & Riepe, M. W. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.12.1352 · Cited by 4
“In recent years, neurodegenerative diseases have been linked to an impairment of mitochondrial energy metabolism (22,23).”
Background
Ultrastructural Changes of the Olfactory Epithelium in Alzheimer's Disease
Jafek, B. W., Eller, P. M., Johnson, E. W., et al. (1992) · American Journal of Rhinology · doi:10.2500/105065892781976646 · Cited by 4
Self-citation
Fueling Alzheimer’s Disease: Where Does Immunometabolism Stand?
Correia, S. C., Perry, G. L., & Moreira, P. I. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240787 · Cited by 3
Human skeletal muscle mitochondrial pathways are impacted by a neuropathologic diagnosis of Alzheimer's disease
Johnson, C. N., Evans, M. R., Blankenship, A. E., John, C. S., Rekowski, M. J., Washburn, M. P., Phan, A. V., Gouvion, C. M., Haeri, M., Swerdlow, R. H., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106916 · Cited by 6
Simulating the slow to fast switch in cytochrome c oxidase catalysis by introducing a loop flip near the enzyme's cytochrome c (substrate) binding site
Alleyne, T. A., Ignacio, D. N., Sampson, V. B., et al. (2016) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1526 · Cited by 3
New Targets for Diagnosis and Treatment Against Alzheimer’s Disease: The Mitochondrial Approach
Maria Jose Perez, J., Jara, C., Muñoz-Urrutia, E., & Quintanilla, R. A. (2016) · InTech eBooks · doi:10.5772/64327 · Cited by 3
The Impact of HAART on Advanced Brain Aging: Implications for Mitochondrial Dysfunction and APP Processing
Campos, J. (2013) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.s10-003 · Cited by 3
Histoenzymology of Oxidases and Dehydrogenases in Peripheral Blood Lymphocytes and Monocytes for the Study of Mitochondrial Oxidative Phosphorylation
de Halac, I. N., Bacman, S. R., & de Kremer, R. D. (2000) · The Histochemical Journal · doi:10.1023/a:1004078705513 · Cited by 3
Mitochondrial Dysfunction and Alzheimer’s Disease
Ghosh, S. S., Miller, S. W., Herrnstadt, C., Fahy, E., Shinobu, L. A., Galasko, D., Thal, L. J., Beal, M. F., Howell, N., Parker, W. D., et al. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_10 · Cited by 3
Self-citation
Editorial: Systemic implications of Alzheimer's disease
Cortés, C. J., Thyfault, J. P., & Wilkins, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1219987 · Cited by 4
“Growing evidence supports metabolic changes are observed within the brain and systemic tissues in AD, including from blood, skin, muscle, and adipose tissue (Parker et al., 1990; Parker, 1991; Kish et al., 1992; Curti et al., 1997; Bosetti et al., 2002; Cardoso et al., 2004; Arbones-Mainar et al., 2010; Mosconi et al.…”
Background
Mitochondrial Function and Neurodegenerative Diseases
Wilkins, H. M., Weidling, I., Koppel, S., Wang, X., von Schulze, A., & Swerdlow, R. H. (2018) · The Molecular and Cellular Basis of Neurodegenerative Diseases · doi:10.1016/b978-0-12-811304-2.00013-4 · Cited by 2
Enhancing mitochondrial functions in neuroinflammatory mouse model using isoflavones-loaded nanoparticles: A potential approach for Alzheimer's disease treatment
Gad, A. A., Tammam, S. N., Ilyas, S., Mansour, S., Youssef, Y. A., Farag, K. S., Abdel-Kader, R. M., & Mathur, S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106252 · Cited by 2
Mitophagy in neurodegeneration: crosstalk between PRKN/parkin-dependent and PRKN-independent pathways
Rasmussen, L. K., Moreira, D. G., Okarmus, J., Simonsen, A., & Meyer, M. (2026) · Autophagy · doi:10.1080/15548627.2026.2711596 · Cited by 4
Intérêt du régime cétogène dans la prise en charge de la maladie d’Alzheimer
Charlot, A., Lernould, A., Plus, I., & Zoll, J. (2023) · Biologie Aujourd hui · doi:10.1051/jbio/2023031 · Cited by 2
Mitochondrial Genome Variants and Alzheimer’s Disease
Kozin, M. S., Кулакова, О. Г., Сергеевич, К. И., Semina, E. V., Kakotkin, V. V., Агапов, М. А., & Favorova, O. O. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297924603174 · Cited by 2
“…the findings that mothers of AD patients are more likely to have AD than their fathers [61], AD endophenotypes are more pronounced in adult offspring if mothers (rather than fathers) suffered from AD [62-64], and that the mitochondrial dysfunction is not limited to the brain tissue damage [65-66].”
Alzheimer’s Disease Pathogenic Mechanisms: Linking Redox Homeostasis and Mitochondria-Associated Metabolic Pathways Through Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)
Rostagno, A. A., & Ghiso, J. A. (2025) · Antioxidants · doi:10.3390/antiox14070812 · Cited by 3
Oxidative stress modulation in neurodegenerative diseases
Carlesi, C., Ienco, E. C., Piazza, S., Gerfo, A. L., Alessi, R., Pasquali, L., & Siciliano, G. (2011) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-011-0053-z · Cited by 2
Idebenone induces oxygen consumption rate modifications in aged rat brain mitochondria
Beta, L., Orsina, N., Celeste, S., Rapuzzi, S., Pifferi, S., Scarlato, G., & Mariani, C. B. (1997) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(96)00742-x · Cited by 2
Behavioral, Electrophysiological, and Biochemical Consequences of Chronic Cytochrome Oxidase Inhibition in Rats
Bennett, M. C., & Rose, G. M. (1998) · Springer eBooks · doi:10.1007/978-1-4757-9936-1_8 · Cited by 2
An Ammonia Hypothesis of Alzheimer Disease
Seiler, N. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5945-0_16 · Cited by 2
Mitochondria in Alzheimer disease : regulatory mechanisms and cell death
Hedskog, L. (2012) · Figshare · Cited by 2
α-Ketoglutarate Dehydrogenase in Alzheimer’s Disease
Blass, J. P., Sheu, K. R., & Tanzi, R. E. (1996) · Neurodegenerative Diseases · doi:10.1007/978-1-4899-0209-2_24 · Cited by 2
Monócitos como indicadores de atividade inflamatória e oxidativa em idosos em déficit cognitivo e com doença de Alzheimer
Giavarotti, L. (2016) · doi:10.11606/t.46.2016.tde-26082016-150838 · Cited by 2
Molecular Mechanisms of Impaired Mitochondrial Gene Expression in Alzheimer’s Disease
Chandrasekaran, K., Hatanpaa, K. J., Liu, L., & Rapoport, S. I. (1998) · Springer eBooks · doi:10.1007/978-1-4757-9936-1_7 · Cited by 2
Peripheral alterations of mitochondrial function and mitophagy in Alzheimer's disease: from fundamental research to clinical perspectives
Eysert, F., Deportes, G., Delaquaize, E., & Chami, M. (2026) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001457 · Cited by 1
Amyloid-β and Mitochondrial Membranes: A Missing Link in Alzheimer’s Pathogenesis
Houfkova, A., & Schmidt, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05786-z · Cited by 2
From Lipids to Mitochondria: Shared Metabolic Alterations in Obesity and Alzheimer’s Disease
Uranga, R. M., & Allani, S. K. (2026) · Cells · doi:10.3390/cells15080672 · Cited by 3
Schizophrenia and Mitochondrial Dysfunction
Akarsu, S. (2014) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.5455/cap.20140121114707 · Cited by 1
S1 nuclease hybrid analysis of mitochondrial DNA amplified by long-distance PCR: rapid screening for small-scale rearrangements
Lundin, K., Wilichowski, E., Ernst, B.-P., et al. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2535 · Cited by 1
Mitochondrial Dysfunction and Neurodegenerative Diseases
Lin, M., & Beal, M. F. (1998) · Springer eBooks · doi:10.1007/978-3-662-12509-0_13 · Cited by 1
Mitochondrial abnormalities in neurological disorders
Ferreira, A. F. F., Singulani, M. P., & de Britto, L. R. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822416-8.00012-9 · Cited by 1
Apoptosis in Neurodegenerative Diseases
Liang, Q., & Zhang, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-381-7_21 · Cited by 1
Unraveling the Role of Mitochondria in Alzheimer’s Disease
Correia, S. C., Moreira, P. I., & Perry, G. L. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190634230.003.0017 · Cited by 1
Recent advances in mitochondrial genetics
Shoffner, J. M., & Wallace, D. C. (1994) · Elsevier eBooks · doi:10.1016/b978-0-7506-0585-4.50016-2 · Cited by 1
Mitochondrial Manipulation as a Treatment for Aging
Smigrodzki, R. M., & Portell, F. R. (2010) · Springer eBooks · doi:10.1007/978-90-481-3999-6_16 · Cited by 1
Aging and Degenerative Diseases
Wallace, D. C. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4843-0_30 · Cited by 1
Energy Failure, Glutamate and Neuropathology: Relevance to Neurodegenerative Disorders
Turski, L., & Ikonomidou, C. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-9203-3_12 · Cited by 1
Serum Prolyl Endopeptidase Activities of Patients with Senile Dementia of the Alzheimer Type and of Those with Vascular Dementia.
Yoshida, K., NAKAJIMA, S., OOTANI, T., et al. (1996) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.21.227 · Cited by 1
“The metabolic disorders of mitochondria that cause abnormal conditions in skeletal muscle and the central nervous system and also cause lactic acidosis are known as mitochondrial myopathy of the brain [ 18], and some AD patients have been reported to carry abnormal enzymes which somewhere relates to mitochondria [19].”
Background
Oxidative stress
Götz, M. E., Künig, G., Riederer, P. F., & Youdim, M. B. H. (1996) · Elsevier eBooks · doi:10.1016/b978-044482529-2/50039-1 · Cited by 1
Multiple System Atrophy : Mitochondria Dysregulation, Reprogramming and Alternative of Neuroprotective AgentsPreprint
Widyarti, S., Wibowo, S., Sabarudin, A., Abhirama, I., & Sumitro, S. B. (2023) · Preprints.org · doi:10.20944/preprints202301.0220.v1 · Cited by 1
Cytochrom C Oxidase Mangel bei Alzheimer’scher Erkrankung
Maurer, I., Zierz, S., & Möller, H. ‐. (1996) · Springer eBooks · doi:10.1007/978-3-7091-6889-9_17 · Cited by 1
Common mtDNA Polymorphisms and Neurodegenerative Disorders
Elson, J. L., & Samuels, D. C. (2011) · Springer eBooks · doi:10.1007/978-0-85729-701-3_4
Increased Glutathione Metabolic Defense Capabilities in Cultured Alzheimer's Diseased Lymphoblast Cell Lines
Shaw, C. M. (2000) · doi:10.15760/etd.1702
The Biological Basis of Dementias
Racchi, M., & Govoni, S. M. (1999) · Springer eBooks · doi:10.1007/978-88-470-2149-5_2
Brain Lipids in Ageing and in Alzheimer's Disease: A Review
Corrigan, F. M., Welsh, S. W., SKINNER, E. R., & Horrobin, D. F. (1994) · Journal of Nutritional Medicine · doi:10.3109/13590849409007232
Mitochondrial Dysfunction, Aging, and Huntington’s Disease
Beal, M. F. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-9203-3_11
A Get‐Together to Tear It Apart
McLelland, G., & Fon, E. A. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch12
Aging, Energy and Alzheimer’s Disease
Bowling, A. C., & Beal, M. F. (1981) · Springer eBooks · doi:10.1007/978-3-662-01135-5_21
ThetRNAGln 4336mitochondrial DNA variant isnot a highpenetrancemutation which
Tysoe, C. J., & Dening, T. (1996)
Is the Point Mutation in Codon 331 of the Mitochondrial ND2 Gene Associated with Alzheimer’s Disease?
Janetzky, B., Schmid, C., Riederer, P. F., et al. (1995) · Advances in behavioral biology · doi:10.1007/978-1-4757-9145-7_99
A pathological investigation of the frontal lobe in post-stroke dementia and other ageing-related dementias
Foster, V. (2015)
Cortical neurons transgenic for human Abeta40 or Abeta42 have similar vulnerability to apoptosis despite their different amyloidogenic properties.
Shiwany, N. A., Xie, J., & Guo, Q. (2009) · PubMed Central · Cited by 6
A characterization of deficits associated with loss of NCB5OR in the mouse brain
Stroh, M. A. (2016) · KU ScholarWorks (The University of Kansas)
Clinical Implications of Osmolytes in Various Human Diseases
Khan, S., Dar, T. A., & Singh, L. R. (2017) · Springer eBooks · doi:10.1007/978-981-10-3707-8_8
Diseases esulting fro Point Mutations
Wallace, D. C., Lott, M. T., Shoffner, J. M., & Brown, M. D. (1992)
Cerebrovascular Dysfunction and Degeneration in Alzheimer’s Disease Pathophysiology
Quintana, D. D. (2020) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7941
Митохондриальные нарушения при болезни Альцгеймера
Sukhorukov, V. S., Mudzhiri, N. M., Voronkova, A. S., Baranich, T. I., Glinkina, V. V., & Illarioshkin, S. N. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521060051
Insilico Identification of Genes and Molecular Pathways during Aging in Drosophila Brain
Parakh, A., Begde, D. N., Dhingra, N., & Sinha, D. (2021) · Advances in Aging Research · doi:10.4236/aar.2021.104005
Análise da biogênese e disfunção mitocondrial na progressão da doença de Alzheimer em camundongos 3xTg-AD.
Singulani, M. P. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2020.tde-23122020-202326
Oxidative stress modulation in neurodegenerative diseases
Carlesi, C., Ienco, E. C., Piazza, S., Gerfo, A. L., Alessi, R., Pasquali, L., & Siciliano, G. (2011) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-011-0055-x
Bestimmung der mitochondrialen Atmungskettenfunktion im Rett-Syndrom mittels hochauflösender Respirometrie
Husemann, V. M. (2023) · doi:10.53846/goediss-9924
Mitochondrial Genomics and Their Clinical Significance
Mishra, S., Tiwari, B. S., & Tiwari, A. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-3169-5_14
Charnolosome in Parkinson's disease
SHARMA, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21752-4.00043-2
Mitochondrial energy production genes affecting reactive oxygen species and ATP synthesis, inflammatory pathways, and neuron viability are differentially expressed in brains of Alzheimer's disease patients
Pflanzer, H. K., Kerns, K. A., Knoble, J. A., Gershon, B. S., Shugoll, J., Shelton, M. G., Coleman, R. A., & Castora, F. J. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251362884
Validation préclinique de l'efficacité de l'ANAVEX2-73 dans des modèles transgénique et non transgénique de la maladie d'Alzheimer
Lahmy, V. (2014) · theses.fr (ABES) · doi:10.70675/23744d67zb26bz4a32zadbfz3931ecca70f5
Génération de cellules souches pluripotentes induites de patients Alzheimer et production d'un modèle de culture en trois dimensions de neurones pour les recherches diagnostiques et thérapeutiques de la maladie d’Alzheimer
Auboyer, L. (2018) · theses.fr (ABES) · doi:10.70675/07243ef7zb974z4ad8z97d9zd046801798b1
Myelin alterations in early stages of Alzheimer's disease and preclinical assessment of the protective and therapeutic potential of neurosteroid 3α-O-allyl-allopregnanolone
Okechukwu, N. G. (2023) · theses.fr (ABES) · doi:10.70675/ec1ca2c3zfad7z48b7zba08z6bb3bb44334f
APOE4 Drives Sex‐ and Diet‐Dependent Effects on AD ‐Like Pathology, Cognition, and Mitochondrial Function
Johnson, C. N., Lysaker, C. R., Cao, X., Csikós, V., Boakye, F. B., Kueck, P. J., Franczak, E., Geiger, P. C., Morris, J. K., Thyfault, J. P., et al. (2026) · FASEB BioAdvances · doi:10.1096/fba.2026-00121
A multi-organ spatial metabolomic atlas of exercising mice reveals neuronal Complex I as a convergent and sufficient axis for tau pathology reduction in PS19Preprint
Medina, T., Quiñones, S., Liu, Z., Wu, L., Ziani, B., Shedlock, C. J., Ma, X., Ryan, A., Larson, R., Soto, C. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.16.732673
Second Section: A single domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.05
References
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.references
Discussion
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.07
Third Section: Design of a dimeric-nanobody specific for Aβ42 oligomers: the Dimeric-DesAb-O
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.06
A multidisciplinary approach for the early diagnosis of Alzheimer’s disease and potential therapeutic applications
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9
Material and Methods
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.03
First Section: Putative CSF biomarkers of Alzheimer’s disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.04
Introduction
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.02
Conclusion and Future Perspectives
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.08
Targeting the mitochondrial functional network: Decoding upstream pathological mechanisms and novel therapeutic paradigms for Alzheimer’s disease
Li, X., Wan, R., Wu, Y., Zhao, Y., Chen, X., Li, Y., Yang, R., Zhang, D., Li, Q., & Luo, C. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103359

Authors: Parker, W. D., Filley, C. M., & Parks, J. K.
Affiliations: University of Colorado Denver (US)
ORCID: Filley, Christopher M.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1990-08
Volume: 40
Issue: 8
Pages: 1302-1302
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.40.8.1302
OpenAlex: W1988731658
Cited by: 598
References: 0
Citations by year: 2026: 19 · 2025: 10 · 2024: 12 · 2023: 20 · 2022: 9 · 2021: 22 · 2020: 25 · 2019: 19 · 2018: 18 · 2017: 18 · 2016: 28 · 2015: 10 · 2014: 10 · 2013: 21 · 2012: 15
FWCI: 7.27
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (7r01ns025382-06)
National Institute of Neurological Disorders and Stroke (NS25382)
National Center for Research Resources (RR-69)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: cytochrome oxidase deficiency, Alzheimer's disease, platelet mitochondria, electron transport chain, mitochondrial dysfunction, systemic disease
MeSH terms: Aged, Alzheimer Disease, Blood Platelets, Electron Transport Complex IV, Electron Transport, Female, Humans, Kinetics, Male, Mitochondria, Reference Values, Cytochrome-c Oxidase Deficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cytochrome oxidase deficiency in Alzheimer’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks